Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 205

1.

β-catenin (CTNNB1) mutations and clinicopathological features of mesenteric desmoid-type fibromatosis.

Huss S, Nehles J, Binot E, Wardelmann E, Mittler J, Kleine MA, Künstlinger H, Hartmann W, Hohenberger P, Merkelbach-Bruse S, Buettner R, Schildhaus HU.

Histopathology. 2013 Jan;62(2):294-304. doi: 10.1111/j.1365-2559.2012.04355.x. Epub 2012 Sep 28.

PMID:
23020601
2.

Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors.

Lazar AJ, Tuvin D, Hajibashi S, Habeeb S, Bolshakov S, Mayordomo-Aranda E, Warneke CL, Lopez-Terrada D, Pollock RE, Lev D.

Am J Pathol. 2008 Nov;173(5):1518-27. doi: 10.2353/ajpath.2008.080475. Epub 2008 Oct 2.

3.

Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool.

Amary MF, Pauwels P, Meulemans E, Roemen GM, Islam L, Idowu B, Bousdras K, Diss TC, O'Donnell P, Flanagan AM.

Am J Surg Pathol. 2007 Sep;31(9):1299-309.

PMID:
17721184
4.

CTNNB1 genotyping and APC screening in pediatric desmoid tumors: a proposed algorithm.

Wang WL, Nero C, Pappo A, Lev D, Lazar AJ, López-Terrada D.

Pediatr Dev Pathol. 2012 Sep-Oct;15(5):361-7. doi: 10.2350/11-07-1064-OA.1. Epub 2012 Feb 28.

PMID:
22372443
5.

CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics.

Le Guellec S, Soubeyran I, Rochaix P, Filleron T, Neuville A, Hostein I, Coindre JM.

Mod Pathol. 2012 Dec;25(12):1551-8. doi: 10.1038/modpathol.2012.115. Epub 2012 Jul 6.

6.

Identification of Familial Adenomatous Polyposis carriers among children with desmoid tumours.

Kattentidt Mouravieva AA, Geurts-Giele IR, de Krijger RR, van Noesel MM, van de Ven CP, van den Ouweland AM, Kromosoeto JN, Dinjens WN, Dubbink HJ, Smits R, Wagner A.

Eur J Cancer. 2012 Aug;48(12):1867-74. doi: 10.1016/j.ejca.2012.01.004. Epub 2012 Feb 2.

PMID:
22305464
7.

[Clinicopathologic and genetic studies of desmoid-type fibromatosis].

Yang JL, Wang J, Zhou XY, Li XQ, Hou YY, Zhu XZ.

Zhonghua Bing Li Xue Za Zhi. 2006 Mar;35(3):145-50. Chinese.

PMID:
16630502
8.

β-Catenin mutation status and outcomes in sporadic desmoid tumors.

Mullen JT, DeLaney TF, Rosenberg AE, Le L, Iafrate AJ, Kobayashi W, Szymonifka J, Yeap BY, Chen YL, Harmon DC, Choy E, Yoon SS, Raskin KA, Hornicek FJ, Nielsen GP.

Oncologist. 2013;18(9):1043-9. doi: 10.1634/theoncologist.2012-0449. Epub 2013 Aug 19.

9.

CTNNB1 S45F mutation predicts poor efficacy of meloxicam treatment for desmoid tumors: a pilot study.

Hamada S, Futamura N, Ikuta K, Urakawa H, Kozawa E, Ishiguro N, Nishida Y.

PLoS One. 2014 May 1;9(5):e96391. doi: 10.1371/journal.pone.0096391. eCollection 2014.

10.

'Difficult to diagnose' desmoid tumours: a potential role for CTNNB1 mutational analysis.

Colombo C, Bolshakov S, Hajibashi S, Lopez-Terrada L, Wang WL, Rao P, Benjamin RS, Lazar AJ, Lev D.

Histopathology. 2011 Aug;59(2):336-40. doi: 10.1111/j.1365-2559.2011.03932.x.

PMID:
21884214
11.

Next-generation sequencing is highly sensitive for the detection of beta-catenin mutations in desmoid-type fibromatoses.

Aitken SJ, Presneau N, Kalimuthu S, Dileo P, Berisha F, Tirabosco R, Amary MF, Flanagan AM.

Virchows Arch. 2015 Aug;467(2):203-10. doi: 10.1007/s00428-015-1765-0. Epub 2015 Apr 3.

PMID:
25838078
12.

Desmoid-type fibromatosis of the head and neck region in the paediatric population: a clinicopathological and genetic study of seven cases.

Flucke U, Tops BB, van Diest PJ, Slootweg PJ.

Histopathology. 2014 May;64(6):769-76. doi: 10.1111/his.12323. Epub 2013 Dec 30.

PMID:
24206198
13.

Gardner fibroma: a clinicopathologic and immunohistochemical analysis of 45 patients with 57 fibromas.

Coffin CM, Hornick JL, Zhou H, Fletcher CD.

Am J Surg Pathol. 2007 Mar;31(3):410-6.

PMID:
17325483
14.

Radiation-induced Sarcomas Occurring in Desmoid-type Fibromatosis Are Not Always Derived From the Primary Tumor.

Verschoor AJ, Cleton-Jansen AM, Wijers-Koster P, Coffin CM, Lazar AJ, Nout RA, Rubin BP, Gelderblom H, Bovée JV.

Am J Surg Pathol. 2015 Dec;39(12):1701-7. doi: 10.1097/PAS.0000000000000510.

PMID:
26414222
15.

Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors.

Salas S, Chibon F, Noguchi T, Terrier P, Ranchere-Vince D, Lagarde P, Benard J, Forget S, Blanchard C, Dômont J, Bonvalot S, Guillou L, Leroux A, Mechine-Neuville A, Schöffski P, Laë M, Collin F, Verola O, Carbonnelle A, Vescovo L, Bui B, Brouste V, Sobol H, Aurias A, Coindre JM.

Genes Chromosomes Cancer. 2010 Jun;49(6):560-8. doi: 10.1002/gcc.20766.

PMID:
20232483
16.

Beta-catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis.

Montgomery E, Torbenson MS, Kaushal M, Fisher C, Abraham SC.

Am J Surg Pathol. 2002 Oct;26(10):1296-301.

PMID:
12360044
17.

Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors.

Matono H, Oda Y, Nakamori M, Tamiya S, Yamamoto H, Yokoyama R, Saito T, Iwamoto Y, Tsuneyoshi M.

Hum Pathol. 2008 Dec;39(12):1802-8. doi: 10.1016/j.humpath.2008.05.005. Epub 2008 Aug 19.

PMID:
18715618
18.

Isolated mesenteric desmoids (mesenteric fibromatosis).

Sacks B, Joffe N, Harris N.

Clin Radiol. 1978 Jan;29(1):95-100.

PMID:
624208
19.
20.

CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study.

Colombo C, Miceli R, Lazar AJ, Perrone F, Pollock RE, Le Cesne A, Hartgrink HH, Cleton-Jansen AM, Domont J, Bovée JV, Bonvalot S, Lev D, Gronchi A.

Cancer. 2013 Oct 15;119(20):3696-702. doi: 10.1002/cncr.28271. Epub 2013 Jul 31.

Items per page

Supplemental Content

Write to the Help Desk